Stay Informed. Stay Healthy. Stay Safe.

Awareness Globe Icon

Awareness

help spread the word about sickle cell disease

Education Bulb Icon

Education

learn about the impact of sickle cell disease

Hope Heart Icon

Hope

find out about research for new treatments and a universal cure

Interactive and informative monthly sessions that connect SiNERGe CBOs and leaders across the region

August 2022

“Heal the Healer: What CBOs Need to Know to Care for Themselves as They Care for Others”

Wanda Whitten-Shurney, MD

CEO & Medical Director

SCDAA – Michigan Chapter

 

 

Coming Soon –

Fundraising and Friendraising

Advocacy 101

Nutrition

Project ECHO is a peer-to-peer learning platform developed at the University of New Mexico. ECHO stands for Extension for Community Healthcare Outcomes.

The Project ECHO website describes the process:

“ECHO participants engage in a virtual community with their peers where they share support, guidance and feedback. As a result, our collective understanding of how to disseminate and implement best practices across diverse disciplines continuously improves and expands.

Participants learn from one another, as knowledge is tested and refined through a local lens.

This continuous loop of learning, mentoring and peer support is what makes ECHO unique, with a long-lasting impact far beyond that of a webinar, e-learning course or telemedicine care.”

SiNERGe sickle cell providers use the ECHO Model to share best practices about care and treatment of SCD.  Similarly, SiNERGe CBOs (community-based organizations) use the model to share best practices about building organizations that effectively serve the sickle cell community.

There are three CBO ECHO series in the Northeast Region:

SiNERGe CBO Regional ECHO

  • Overview: The SiNERGe CBO Collective Impact Initiative hosts a series of peer-to-peer learning sessions [ECHOs] on a range of topics of interest to the region’s community-based organizations. The first three sessions of 2022 will be on Grant Writing and the April session will be a “how to” on organizing Shine the Light community awareness and advocacy events in celebration of World Sickle Cell Awareness Day on June 19.
  • Intended Audience: CBO leaders and staff throughout the Northeast Region
  • Frequency/Schedule: Monthly, 3rd Wednesday, 3p – 4p
  • Point of Contact: Andrea Matthews, Children’s Sickle Cell Foundation, Inc., founder@cscfkids.org and Michael Matthews, Children’s Sickle Cell Foundation, Inc., mmatthews@cscfkids.org

NY CBO ECHO on Stigma in the ED

  • Overview: One of the most critical and unjust disparities for individuals living with SCD is the stigma they face when coming to an Emergency Department [ED] to treat their pain crisis (Rivlin). The goal of this ECHO project is to reduce sickle cell-related implicit biases of ED providers and staff by incorporating an education module into existing continuing education programs at hospitals throughout NY State.
  • Intended Audience: CBO leaders and providers in NYS
  • Frequency/Schedule: Monthly, last Thursday, 1p – 2p
  • Point of Contact: Candice Deler, Candice’s Sickle Cell Fund, cscfinc@gmail.com

PA Living Well with Sickle Cell Project ECHO

Overview: The Pennsylvania Sickle Cell Providers Network (PASCPN) is a state-wide network of hospitals and community-based organizations whose mission is to collectively address the needs of those living with sickle cell disease (SCD) as vital partners for whole-person care, improving access to quality care within health systems and the community, expanding opportunities for collaboration across the Commonwealth of Pennsylvania. The goal of this ECHO project is to strengthen the state-wide network of hospital and community partners, through Project ECHO sessions, promote collaboration, share best and promising practices to increase access to quality health care and community-based services for every person living with SCD in Pennsylvania, from birth across the lifespan.

  • Intended Audience: Pennsylvania Sickle Cell Providers Network Members
  • Frequency/Schedule: TBA
  • Point of Contact: Andrea M. Matthews, Founder, Children’s Sickle Cell Foundation, Inc. (CSCF, Inc.), founder@csckfids.org

ECHO 2.0 is supported by HRSA. The views expressed are those of the speaker(s) and participants and do not represent official views of, nor an endorsement by HRSA, Johns Hopkins or the WEPSCF. ECHO 2.0 is presented for information purposes only. Individuals should seek advice, guidance and direction from their qualified health care provider.

INDIVIDUALS LIVING WITH SCD IN THE U.S.

HOSPITALIZATIONS ANNUALLY DUE TO SCD IN THE U.S.

NEW DRUGS APPROVED BY FDA SINCE 2017

THERAPIES CURRENTLY IN PHASE III CLINICAL TRIALS